|
The following was reported to gore:
on (b)(6) 2026, a patient underwent an endovascular procedure for abdominal aorta aneurysm treatment.Gore® excluder® thoracoabdominal branch endoprosthesis (tambe) was implanted.Gore® viabahn® vbx balloon expandable endoprosthesis (vbx devices) were implanted as branch devices in the visceral arteries.As reported, the physician stated a potential kink of the 6mm vbx device in right renal artery was noted post operatively.The patient experienced high blood pressure after the index procedure.This resolved after the patient's first bowel movement.On (b)(6) 2026, the vbx device kink was confirmed and reintervention was performed.The vbx device was relined with a 7mm x 30mm protege everflex stent.Result was resolution of the kink.The physician reportedly stated the cause of kink was external compression of the arcuate ligament.
|
|
Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.H6 - code c19: review of device manufacturing record history confirmed device met pre-release specifications.H6 - code b01: the device remains implanted; therefore, it was not available for analysis.No images enabling direct assessment of product performance were available for evaluation.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|